ArticleJournal of translational medicine2018

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.

Janet Retseck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.